Hodges Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-54,553
Closed -$1.67M 228
2023
Q1
$1.67M Sell
54,553
-16,915
-24% -$454K 0.14% 133
2022
Q4
$2M Buy
71,468
+5,878
+9% +$150K 0.17% 117
2022
Q3
$1.53M Sell
65,590
-80,722
-55% -$2.44M 0.25% 98
2022
Q2
$4.94M Buy
146,312
+139,802
+2,147% +$4.9M 0.5% 63
2022
Q1
$227K Sell
6,510
-220
-3% -$7.52K 0.02% 226
2021
Q4
$205K Sell
6,730
-770
-10% -$25.1K 0.01% 234
2021
Q3
$246K Buy
+7,500
New +$240K 0.02% 223

Other funds holding OGN

Hodges Capital Management's OGN Position: Q2 2023 in Review

Hodges Capital Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 54,553 shares — an estimated $1.67M sold.

Hodges Capital Management first reported a position in OGN in Q3 2021 and held it in 7 quarters. The position peaked at $4.94M in Q2 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Hodges Capital Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Hodges Capital Management sold 54,553 Organon & Co shares in Q2 2023, an estimated $1.67M.
  • Hodges Capital Management first reported a position in Organon & Co in Q3 2021 and held it in 7 quarters.
  • Hodges Capital Management's Organon & Co position peaked at $4.94M in Q2 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Hodges Capital Management's 13F filing for Q2 2023, filed 7 Aug 2023.